HDFC Securities: Sun Pharma’s Specialty Recovery Is Encouraging

A recovery in specialty business, improved gross margin and lower other expenses helped deliver a beat on ebitda and net income.

HDFC Securities Retail Research

04 Nov 2020, 06:24 PM IST

The Sun Pharmaceutical Industries Ltd. headquarters stand in Mumbai, India (Photographer Kanishka Sonthalia/Bloomberg)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

HDFC Securities: Sun Pharma’s Specialty Recovery Is Encouraging

A recovery in specialty business, improved gross margin and lower other expenses helped deliver a beat on ebitda and net income.

Choose a plan